1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for 'CFS'.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 21st April 2025 is here.
    Dismiss Notice
  3. Welcome! Read the Core Purpose and Values of our forum.
    Dismiss Notice

cyclophosphamide

  1. Jaybee00
    Thread

    Review High-dose Cyclophosphamide Without Stem Cell Rescue in Autoimmune Diseases: A Systematic Review Carvalho 2024

    Abstract High-dose cyclophosphamide without stem cell rescue is a radical therapy for refractory autoimmune diseases. The objective was to...
    Thread by: Jaybee00, Jan 14, 2025, 2 replies, in forum: 'Conditions related to ME/CFS' news and research
  2. SNT Gatchaman
    Thread

    Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in [ME/CFS], 2024, Rekeland, Fluge, Mella et al.

    Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome...
    Thread by: SNT Gatchaman, Jul 24, 2024, 4 replies, in forum: ME/CFS research
  3. Dolphin
    Thread

    Thesis Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Clinical trials, medical treatment and pathomechanisms, 2024, Rekeland

    https://bora.uib.no/bora-xmlui/handle/11250/3127770 Source: University of Bergen Date: May 2, 2024 Myalgic Encephalomyelitis/Chronic Fatigue...
    Thread by: Dolphin, Apr 26, 2024, 57 replies, in forum: ME/CFS research
  4. John Mac
    Thread

    Reduced endothelial function in ME/CFS - results from open-label cyclophosphamide intervention study Fluge & Mella 2021

    Full title: Reduced endothelial function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - results from open-label cyclophosphamide...
    Thread by: John Mac, Mar 2, 2021, 20 replies, in forum: ME/CFS research
  5. Kalliope
    Thread

    Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study - 2020 - Rekeland, Mella, Fluge et al

    published in frontiers in Medicine - Family Medicine and Primary Care Results: The overall response rate by Fatigue score was 55.0% (22 of 40...
    Thread by: Kalliope, Apr 30, 2020, 130 replies, in forum: ME/CFS research
  6. Jaybee00
    Thread

    Inhibition of Upf2-Dependent Nonsense-Mediated Decay Leads to Behavioral and Neurophysiological Abnormalities by Activating the Immune Response

    https://www.cell.com/neuron/pdfExtended/S0896-6273(19)30733-0 Used cyclophosphamide to treat autism symptoms in mice by reducing brain...
    Thread by: Jaybee00, Nov 12, 2019, 10 replies, in forum: Other health news and research
  7. Cheshire
    Thread

    Øystein Fluge and Olav Mella's ME/CFS research

    Rituximab (RituxME) Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case...
    Thread by: Cheshire, Oct 22, 2017, 0 replies, in forum: Science library (Read only)
Showing results 1 to 7 of 7